• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤厚度评分作为系统性硬化症器官受累的替代标志物:一项回顾性观察研究。

Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.

机构信息

Department of Dermatology, The University of Tokyo Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 1138655, Japan.

Department of Biostatistics, School of Public Health, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

出版信息

Arthritis Res Ther. 2019 May 28;21(1):129. doi: 10.1186/s13075-019-1919-6.

DOI:10.1186/s13075-019-1919-6
PMID:31138286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6540426/
Abstract

BACKGROUND

Previous studies have shown the relationship between higher skin thickness score and the existence of organ involvements in systemic sclerosis (SSc). Here, we firstly investigated the correlation between skin thickness score and quantitative measurements of each organ involvement in Japanese patients with SSc.

METHODS

All Japanese SSc patients hospitalized to our clinic for initial evaluation of SSc were selected. Skin thickness was evaluated by modified Rodnan total skin thickness score (mRSS). Relationship between mRSS and prevalence or incidence of organ involvements was examined by logistic analyses. Correlation between mRSS and quantitative measurements of organ involvements was examined by correlation analyses and regression analyses.

RESULTS

We recruited 198 patients into our study. The mean disease duration was 7.3 years with the mean follow-up duration of 3.2 years. Multivariate logistic regression analyses revealed that higher mRSS is related to higher prevalence of interstitial lung disease (P < 0.05), restrictive impairment (P < 0.01), and diffusion impairment (P < 0.05) of the lung. Correlation analyses revealed mRSS negatively correlates with forced vital capacity (P < 0.001) and diffusing capacity (P < 0.001) of the lung. Correlation between longitudinal change of mRSS and that of forced vital capacity (P < 0.05) or diffusing capacity (P < 0.001) of the lung was also demonstrated.

CONCLUSIONS

Skin thickness score significantly correlates with quantitative measurements of lung involvement in Japanese patients with SSc.

摘要

背景

先前的研究表明,皮肤厚度评分与系统性硬化症(SSc)器官受累的存在之间存在关系。在这里,我们首次研究了皮肤厚度评分与日本 SSc 患者每种器官受累的定量测量之间的相关性。

方法

选择所有因 SSc 初次评估而住院到我院的日本 SSc 患者。采用改良的 Rodnan 总皮肤厚度评分(mRSS)评估皮肤厚度。通过逻辑回归分析检查 mRSS 与器官受累的患病率或发病率之间的关系。通过相关分析和回归分析检查 mRSS 与器官受累的定量测量之间的相关性。

结果

我们共招募了 198 名患者参加本研究。平均疾病持续时间为 7.3 年,平均随访时间为 3.2 年。多变量逻辑回归分析显示,较高的 mRSS 与间质性肺病(ILD)的高患病率(P<0.05)、限制性损害(P<0.01)和肺弥散功能障碍(P<0.05)有关。相关分析显示 mRSS 与肺的用力肺活量(P<0.001)和弥散量(P<0.001)呈负相关。还证明了 mRSS 的纵向变化与用力肺活量(P<0.05)或弥散量(P<0.001)的纵向变化之间的相关性。

结论

皮肤厚度评分与日本 SSc 患者肺受累的定量测量显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/6540426/ce30afc07da0/13075_2019_1919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/6540426/fe678ce4c79a/13075_2019_1919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/6540426/ce30afc07da0/13075_2019_1919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/6540426/fe678ce4c79a/13075_2019_1919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/6540426/ce30afc07da0/13075_2019_1919_Fig2_HTML.jpg

相似文献

1
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.皮肤厚度评分作为系统性硬化症器官受累的替代标志物:一项回顾性观察研究。
Arthritis Res Ther. 2019 May 28;21(1):129. doi: 10.1186/s13075-019-1919-6.
2
High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.系统性硬皮病皮肤高频超声:一项探索性研究,旨在检查与疾病活动的相关性,并定义最小可检测差异。
Arthritis Res Ther. 2018 Aug 16;20(1):181. doi: 10.1186/s13075-018-1686-9.
3
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.基于计算机视觉的系统性硬化症皮肤疾病高通量定量组织学。
Arthritis Res Ther. 2020 Mar 14;22(1):48. doi: 10.1186/s13075-020-2127-0.
4
Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.早期系统性硬化症日本患者皮肤硬化和肺功能预后因素的研究:一项多中心前瞻性观察研究。
Rheumatology (Oxford). 2012 Jan;51(1):129-33. doi: 10.1093/rheumatology/ker333. Epub 2011 Nov 9.
5
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.皮肤改善是早期弥漫性皮肤系统性硬皮病其他器官系统发生有利变化的替代指标。
Rheumatology (Oxford). 2020 Jul 1;59(7):1715-1724. doi: 10.1093/rheumatology/kez529.
6
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.皮肤增厚的早期轨迹与系统性硬化症的严重程度和死亡率相关。
Arthritis Res Ther. 2020 Feb 18;22(1):30. doi: 10.1186/s13075-020-2113-6.
7
Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.评估硬皮病临床试验联合会关于硬皮病改良 Rodnan 皮肤评分评估的培训建议。
Int J Rheum Dis. 2019 Jun;22(6):1036-1040. doi: 10.1111/1756-185X.13523. Epub 2019 Mar 6.
8
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.系统性硬化症患者甲襞微血管损伤与皮肤受累的相关性。
Microvasc Res. 2019 Sep;125:103874. doi: 10.1016/j.mvr.2019.04.004. Epub 2019 Apr 8.
9
High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.皮肤硬化症负担高与系统性硬化症和重叠综合征患者严重的器官受累有关。
Rheumatol Int. 2018 Dec;38(12):2279-2288. doi: 10.1007/s00296-018-4156-4. Epub 2018 Sep 11.
10
Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.早发型重度系统性硬化症的临床特征预测因素:一项多中心前瞻性观察性日本队列研究分析。
J Dermatol. 2024 Oct;51(10):1290-1297. doi: 10.1111/1346-8138.17403. Epub 2024 Sep 5.

引用本文的文献

1
BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial.巴瑞替尼治疗系统性硬化症患者(BASICS):一项前瞻性、开放标签、随机试验。
Clin Rheumatol. 2025 May 17. doi: 10.1007/s10067-025-07433-9.
2
Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients.泰国系统性硬化症患者皮肤厚度进展率峰值与心肺受累发病之间的相关性
J Clin Med. 2025 Mar 27;14(7):2281. doi: 10.3390/jcm14072281.
3
Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases.

本文引用的文献

1
Systemic sclerosis.系统性硬化症。
J Dermatol. 2018 Feb;45(2):128-138. doi: 10.1111/1346-8138.14153. Epub 2017 Dec 10.
2
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature.硬皮病皮肤溃疡的定义、分类和治疗策略:我们的经验和文献回顾。
Autoimmun Rev. 2018 Feb;17(2):155-164. doi: 10.1016/j.autrev.2017.11.020. Epub 2017 Dec 2.
3
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
硬皮病及相关纤维化疾病中髓系细胞的跨组织分布。
Curr Opin Rheumatol. 2024 Nov 1;36(6):379-386. doi: 10.1097/BOR.0000000000001047. Epub 2024 Sep 11.
4
Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study.系统性硬化症患者左心室收缩功能障碍的临床病程及预测因素:一项队列研究。
Rheumatol Immunol Res. 2024 Jul 15;5(2):107-116. doi: 10.1515/rir-2024-0014. eCollection 2024 Jun.
5
Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration.《加利福尼亚大学洛杉矶分校硬皮病临床试验联盟胃肠道仪器日本版的可靠性、有效性和敏感性:在静脉注射免疫球蛋白给药疗效评估中的应用》
J Dermatol. 2024 Jun;51(6):741-751. doi: 10.1111/1346-8138.17202. Epub 2024 Apr 1.
6
Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease.回顾性比较研究 JAK 抑制剂(托法替布)治疗系统性硬化症相关间质性肺病的疗效。
Clin Rheumatol. 2023 Oct;42(10):2823-2832. doi: 10.1007/s10067-023-06660-2. Epub 2023 Jun 19.
7
Salivary Antioxidant Profile in Patients with Systemic Sclerosis and Periodontitis.系统性硬化症和牙周炎患者的唾液抗氧化谱。
Mediators Inflamm. 2023 Apr 24;2023:7886272. doi: 10.1155/2023/7886272. eCollection 2023.
8
Interleukin-32 as a biomarker in rheumatic diseases: A narrative review.白细胞介素-32 作为风湿性疾病的生物标志物:叙事性综述。
Front Immunol. 2023 Feb 15;14:1140373. doi: 10.3389/fimmu.2023.1140373. eCollection 2023.
9
Assessment of disease outcome measures in systemic sclerosis.系统性硬化病的疾病结局评估。
Nat Rev Rheumatol. 2022 Sep;18(9):527-541. doi: 10.1038/s41584-022-00803-6. Epub 2022 Jul 20.
10
Autoantibody Landscape Revealed by Wet Protein Array: Sum of Autoantibody Levels Reflects Disease Status.湿蛋白芯片揭示的自身抗体全景:自身抗体水平的总和反映疾病状态。
Front Immunol. 2022 May 4;13:893086. doi: 10.3389/fimmu.2022.893086. eCollection 2022.
托西珠单抗皮下注射治疗系统性硬化症的安全性和有效性:一项 II 期随机对照试验(faSScinate)开放性研究阶段的结果。
Ann Rheum Dis. 2018 Feb;77(2):212-220. doi: 10.1136/annrheumdis-2017-211682. Epub 2017 Oct 24.
4
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.用于系统性硬化症临床试验的改良罗德南皮肤评分的标准化。
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18. doi: 10.5301/jsrd.5000231.
5
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.一项关于利妥昔单抗治疗系统性硬化症相关间质性肺病的多中心、开放标签、对比研究。
Semin Arthritis Rheum. 2017 Apr;46(5):625-631. doi: 10.1016/j.semarthrit.2016.10.003. Epub 2016 Oct 13.
6
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.托西珠单抗皮下注射治疗系统性硬化症成人患者的安全性和有效性(faSScinate):一项 2 期、随机、对照试验。
Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5.
7
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.美国风湿病学会早期弥漫性皮肤系统性硬化症临床试验临时综合反应指数
Arthritis Care Res (Hoboken). 2016 Feb;68(2):167-78. doi: 10.1002/acr.22804.
8
Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.简报:肺功能检查:在硬皮病相关间质性肺病的早期检测和筛查中,存在大量假阴性结果。
Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.
9
Abnormal B lymphocyte activation and function in systemic sclerosis.系统性硬化症中异常的B淋巴细胞激活与功能
Ann Dermatol. 2015 Feb;27(1):1-9. doi: 10.5021/ad.2015.27.1.1. Epub 2015 Feb 3.
10
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.早期弥漫性系统性硬化症皮肤和肌肉骨骼疾病相关指标及对其变化的反应性。
Arthritis Care Res (Hoboken). 2014 Nov;66(11):1731-9. doi: 10.1002/acr.22339.